BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21919872)

  • 1. Duloxetine in the treatment of depression: an overview.
    Monteleone F; Caputo M; Tecce MF; Capasso A
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):174-83. PubMed ID: 21919872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toddler Sleep Challenges: All in a Day's Work.
    Barnes AJ; Kroupina M; Perry N; Augustyn M
    J Dev Behav Pediatr; 2019 Dec; 40(9):762-764. PubMed ID: 31693647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["It was me or them!": the no exit escape of a future author of psychotic double parricide].
    Bouchard JP
    Encephale; 2013 Apr; 39(2):115-22. PubMed ID: 23095589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
    J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical forms of post-traumatic depression].
    Auxéméry Y
    Encephale; 2015 Sep; 41(4):346-54. PubMed ID: 25238908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine for childhood depression with pain and dissociative symptoms.
    Desarkar P; Das A; Sinha VK
    Eur Child Adolesc Psychiatry; 2006 Dec; 15(8):496-9. PubMed ID: 16732464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics.
    Perahia DG; Kajdasz DK; Royer MG; Walker DJ; Raskin J
    Int Clin Psychopharmacol; 2006 Sep; 21(5):285-95. PubMed ID: 16877900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Social and professional effects of hip prosthetic replacment on people under 50 years of age].
    Xenard J
    Eur J Orthop Surg Traumatol; 1996 Dec; 6(4):229-234. PubMed ID: 28315097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom.
    Shi N; Cao Z; Durden E; Schacht A; Torres A; Happich M
    J Med Econ; 2012; 15(4):672-80. PubMed ID: 22390770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.